Handheld Capillary Blood Lactate Analyzer as an Accessible and Cost-Effective Prognostic Tool for the Assessment of Death and Heart Failure Occurrence during Long-Term Follow-Up

Table 1

Patient characteristics according to the type of myocardial infarction.

	STEMI ()	NSTEMI ()
Age	59.85	62.86	ns
Women	21 (35%)	25 (30%)	ns
Hypertension	50 (83%)	76 (89%)	ns
Diabetes	20 (33%)	20 (24%)	ns
Smoking	36 (60%)	37 (44%)	ns
Atrial fibrillation	5 (8%)	6 (7%)	ns
Systolic BP (mmHg)	136	140	ns
Diastolic BP (mmHg)	81	83	ns
Shock	7 (12%)	1 (1%)	ns
IABP	2 (3%)	0 (0%)	ns
eGFR < 60 (ml/min/)	5 (8%)	11 (13%)	ns
Previous CABG	1 (2%)	3 (4%)	ns
Previous cardiac arrest	3 (5%)	2 (2%)	ns
GPIIb/IIIa inhibitors	29 (48%)	8 (9%)
EDV (ml)	97	90	ns
LVEF (%)	42	49
Hospitalization time (days)	8.8	8.0	ns
Heart rate (1/min)	78	82	ns
BMI	27.7	28.6	ns
Time from symptom onset to FMC (hours)	; 6.00 (3.25, 9.00)	; 12.00 (8.00, 24.00)

Abbreviations: BMI: body mass index. BP: blood pressure. CABG: coronary artery bypass grafts. EDV: end-diastolic volume. eGFR: estimated glomerular filtration rate. GPIIb/IIIa: glycoprotein IIb/IIIa inhibitors. IABP: intra-aortic balloon pump. LVEF: left ventricular ejection fraction. NSTEMI: non-ST segment elevation myocardial infarction. STEMI: ST segment elevation myocardial infarction.